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ttp://dx.doi.org/10.1016/j.ajpath.2015.01.024Lyme neuroborreliosis, caused by the spirochete Borrelia burgdorferi, affects both peripheral and central
nervous systems. We assessed a causal role for inﬂammation in Lyme neuroborreliosis pathogenesis by
evaluating the induced inﬂammatory changes in the central nervous system, spinal nerves, and dorsal
root ganglia (DRG) of rhesus macaques that were inoculated intrathecally with live B. burgdorferi and
either treated with dexamethasone or meloxicam (anti-inﬂammatory drugs) or left untreated. ELISA of
cerebrospinal ﬂuid showed signiﬁcantly elevated levels of IL-6, IL-8, chemokine ligand 2, and CXCL13
and pleocytosis in all infected animals, except dexamethasone-treated animals. Cerebrospinal ﬂuid and
central nervous system tissues of infected animals were culture positive for B. burgdorferi regardless of
treatment. B. burgdorferi antigen was detected in the DRG and dorsal roots by immunoﬂuorescence
staining and confocal microscopy. Histopathology revealed leptomeningitis, vasculitis, and focal
inﬂammation in the central nervous system; necrotizing focal myelitis in the cervical spinal cord;
radiculitis; neuritis and demyelination in the spinal roots; and inﬂammation with neurodegeneration in
the DRG that was concomitant with signiﬁcant neuronal and satellite glial cell apoptosis. These changes
were absent in the dexamethasone-treated animals. Electromyography revealed persistent abnormalities
in F-wave chronodispersion in nerve roots of a few infected animals; which were absent in
dexamethasone-treated animals. These results suggest that inﬂammation has a causal role in the
pathogenesis of acute Lyme neuroborreliosis. (Am J Pathol 2015, 185: 1344e1360; http://dx.doi.org/
10.1016/j.ajpath.2015.01.024)Supported by the NIH National Institute of Neurologic Disorders and
Stroke grant NS048952 (M.T.P.) and NIH National Center for Research
Resources and the Ofﬁce of Research Infrastructure Programs grant
P51OD011104/P51RR000164.
Disclosures: None declared.Lyme disease is caused by infection with the spirochete
Borrelia burgdorferi (Bb). The spirochetes enter the host’s
skin via the bite of infected Ixodes scapularis ticks, causing
an inﬂammatory response that may result in the appearance
of a slowly radiating erythematous rash called erythema
migrans, followed commonly, after spirochetal dissemina-
tion, by early ﬂu-like symptoms, including headaches, fever,
fatigue, malaise, and diffuse aches and pains.1 The dissemi-
nating spirochetes show distinct organotropisms, and mani-
festations of infection can include arthritis, carditis, and
neurologic deﬁcits.2,3
Nervous system involvement in Lyme disease, termed
Lyme neuroborreliosis (LNB), is manifest in approximately
15% of Lyme disease patients and may affect both the
central (CNS) and peripheral nervous systems (PNS). CNS
involvement may result in symptoms such as headache,stigative Pathology.
.fatigue, memory loss, learning disability, or depression.
LNB of the PNS may result in facial nerve palsy, limb pain,
sensory loss, and/or muscle weakness.4e6
Clinical ﬁndings of patients with LNB typically show the
neurologic triad of meningitis, cranial neuritis, and radi-
culoneuritis,1,7 commonly described as meningoradiculitis
(also known as Garin-Bujadoux-Bannwarth syndrome).
Lyme meningitis presents mostly as leptomeningitis, char-
acterized by lymphocytic pleocytosis in the cerebrospinal
ﬂuid (CSF).8 LNB patients may experience encephalopathy,
Pathogenesis of Lyme Neuroborreliosisencephalitis, and encephalomyelitis concomitant with white
matter inﬂammation in the brain and spinal cord.9e11
Neurogenic pain along the back, radiating into the legs and
foot, accompanied with weakness, numbness, and tingling in
the legs, described as radiculitis or radiculoneuritis, is the
most common starting symptom in patients with peripheral
LNB.12,13 Motor deﬁcits are also common, and pain and
motor deﬁcits are classically dermatomal or localized to the
limb closest to the tick bite, suggesting a pathology that
involves sensory neurons that arise from dorsal root ganglia
(DRG) in that area of the spinal cord.14 Other mono-
neuropathies and plexopathies that result in pain, loss of
motor control, and sensory deﬁcits also occur, with patients
exhibiting electrophysiologic abnormalities indicative of
widespread axonal damage.12e16 A few case reports also
suggest an association with demyelinating neuropathies
whereby nerve conduction studies (NCSs) showed conduc-
tion slowing and abnormal temporal dispersion, consistent
with demyelinating neuropathy.17
Importantly, pathologic examinations of CNS lesions
from cases of human LNB have revealed lymphocyte and
plasma cell inﬁltration in the leptomeninges and peri-
vascular inﬁltrates of immune cells adjacent to white matter
lesions in the brain and transverse myelitis lesions in the
spinal cord,18e25 whereas lesions from patients with PNS
Lyme disease have shown inﬂammation in the nerve roots
and DRG and patchy multifocal axonal loss accompanied
with epineural perivascular inﬂammatory inﬁltrates or
perineuritis.12,26,27
The rhesus macaque has proved to be an accurate model
of human nervous system Lyme disease.28e31 In one study,
almost all of the experimental animals demonstrated peri-
vascular inﬂammatory inﬁltrates, multifocal axonal changes,
and NCS results that were consistent with mononeuropathy
multiplex.32 Sensory ganglia of rhesus macaques that were
infected with Bb showed various degrees of necrosis, and
peripheral nerve specimens showed multifocal axonal
degeneration and regeneration and occasional perivascular
inﬂammatory cellular inﬁltrates in which macrophages
showed positive immunostaining with a monoclonal anti-
body against a 7.5-kDa lipoprotein of Bb.32 Infection in
nerve roots, DRG, and involvement of the spinal cord was
also observed in the rhesus monkey model of LNB.33e35
Previously, we reported that rhesus macaques that were
inoculated with live Bb into the cisterna magna showed
increased levels of IL-6, IL-8, chemokine ligand 2 (CCL2),
and CXCL13 in the CSF within 1 week after inoculation,
accompanied by a monocytic/lymphocytic pleocytosis.35 In
addition, we observed elevated levels of neuronal and sat-
ellite glial cell apoptosis in the DRG of infected rhesus
macaques, compared with uninfected controls. Importantly,
the acute neurologic manifestations observed histopatho-
logically as leptomeningitis and radiculitis were concomi-
tant with the inﬂammatory response mounted by the Lyme
disease spirochete.35 Our aim was to evaluate whether
inﬂammation as induced by the Lyme disease spirochete hasThe American Journal of Pathology - ajp.amjpathol.orga causal role in mediating the pathogenesis of acute LNB.
We hypothesized that Bb induces the production of in-
ﬂammatory mediators in glial and neuronal cells and that
this response has a role in potentiating glial and neuronal
apoptosis. We addressed this hypothesis by evaluating the
inﬂammatory changes induced in the CNS, spinal nerves,
and DRG of rhesus macaques that were inoculated with live
Bb into the cisterna magna and were either left untreated or
were given the anti-inﬂammatory drug dexamethasone
(Dex), a steroid that inhibits the expression of several im-
mune mediators,36 or meloxicam (Mel), a nonsteroidal anti-
inﬂammatory drug that inhibits cyclooxygenase-2.37 Rhesus
macaques were studied for either 8 or 14 weeks. In accor-
dance with our hypothesis we found that the effective sup-
pression of inﬂammation by Dex treatment resulted in
inhibition of glial and neuronal damage, suggesting that
inﬂammation has a causal role in the pathogenesis of LNB.
Here, we report the results of these studies.
Materials and Methods
Spirochetal Inoculum
Bb strain B31 clone 5A19 spirochetes, passage one, isolated
from an ear biopsy of a previously infected mouse were
grown in Barbour-Stoenner-KellyeHmedium supplemented
with 6% rabbit serum and antibiotics (rifampicin at 45.4
mg/mL, phosphomycin at 193 mg/mL, and amphotericin at
0.25 mg/mL; Sigma-Aldrich, St. Louis, MO) to late loga-
rithmic phase under microaerophilic conditions. The inoc-
ulum that contained a suspension of 1  108 spirochetes/mL
in RPMI 1640 medium (Invitrogen, Grand Island, NY) was
prepared as described earlier.35
Animals, Drug Treatments, and Intrathecal Inoculation
Fourteen 3- to 7-year-old male rhesus macaques (Macaca
mulatta) of Chinese origin were used in this study. Twelve
rhesus macaques were anesthetized and inoculated intra-
thecally into the cisterna magna with 1  108 live spiro-
chetes suspended in 1 mL of RPMI 1640 medium, whereas
two rhesus macaques were left uninfected but received 1 mL
of RPMI 1640 medium after removing an equivalent vol-
ume of CSF, after an inoculation protocol that was approved
by the Institutional Animal Care and Use Committee of the
Tulane National Primate Research Center. Of the twelve
Bb-inoculated rhesus macaques, four were left untreated,
four were treated with Dex, and four were treated with Mel.
Half of the rhesus macaques in each group of four were
studied for a period of 8 weeks after inoculation and the
other half for 14 weeks. One of the uninfected controls was
also studied for 8 weeks and the other for 14 weeks.
Drug treatments were started 1 week before inoculation
and consisted of Dex (PAR Pharmaceuticals, Spring Valley,
NY), 4-mg tablets, given at a dose of 2 mg/kg once a day for
1 week and subsequently at 1 mg/kg once a day for the1345
Ramesh et alremainder of the study, and Mel (Metacam; Boehringer
Ingelheim, St. Joseph, MO), 1.5 mg/mL, given at a dose of
0.18 mg/kg on day 1 (loading dose) and subsequently at 0.09
mg/kg once a day for the remainder of the study. These doses
are consistent with standard veterinary regimens for the
chosen drugs in nonhuman primates (Nonhuman Primate
Formulary, http://www.primatevets.org/Content/ﬁles/Public/
education/Nonhuman%20Primate%20Formulary.xls, last
accessed December 22, 2014).38 The drugs (liquid or crushed
tablets) were placed in a piece of fruit (bananas or apples but
not citrus fruits) for daily administration. The Bb-infected
untreated rhesus macaques and the uninfected controls
received the same fruit devoid of medication.
Evaluation of CSF Pleocytosis, Monitoring of CNS
Inﬂammation, and Bb Culture of CSF and CNS Tissues
The enumeration of cells in the CSF for evaluation of pleo-
cytosis and preparation of CSF cell pellets for Bb culture was
performed as previously described.35 To monitor CNS
inﬂammation, 0.5 to 1.0 mL of CSF and serum (5 mL of
blood) were collected at base line (day 0) before inoculation,
subsequently after inoculation on a weekly basis for 4 weeks,
and then once every 2weeks until the end of the study for each
animal. Rhesus macaques were euthanized as per a procedure
consistent with the recommendations of the American Vet-
erinary Medical Association’s Panel on Euthanasia.
Tissues from various regions of the brain and spinal cord
that were collected at necropsy and CSF cell pellets that were
prepared from samples drawn at the various time points
described in the paragraph above were incubated in 10 mL of
Barbour-Stoenner-KellyeH medium supplemented with
rabbit serum and antibiotics for culture of spirochetes under
microaerophilic conditions, as previously described.35
Quantiﬁcation of Immune Mediators in CSF and Serum
and Detection of Anti-VlsE (C6) Antibodies in Serum
The concentrations of cytokines and chemokines present in
CSF and serum were quantiﬁed with the MILLIPLEX MAP
Non-Human Primate Cytokine Magnetic Bead Panel, Pre-
mixed 23 Plex, PCYTMG-40 K-PX23 Cytokine-Chemokine
Array kit (Millipore, Billerica, MA) according to the manu-
facturer’s instructions. The analytes detected by this panel are
as follows: granulocyte CSF, granulocyte-macrophage CSF,
interferon-g, IL-10, IL-12/23 (p40), IL-13, IL-15, IL-17,
IL-18, IL-1ra, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, CCL2,
CCL3, CCL4, transforming growth factor (TGF)-a, tumor
necrosis factor, vascular endothelial growth factor, and
sCD40L. The multiplex plate was read with a Bio-Plex 200
Suspension Array Luminex System (Bio-Rad, Hercules,
CA). CXCL13 concentration was measured with a sandwich
ELISA (R&D Systems, Minneapolis, MN). The cutoff line
for positive sandwich ELISA values was set as the mean
value for CXCL13 of all of the preinfection and control CSF
specimens plus three times the SD of that mean.1346The levels of serum antibody to the VlsE (C6) peptide
were quantiﬁed with ELISA by using a procedure described
previously.39 The mean value of all of the preimmune serum
samples plus three times the SD of that mean was used to set
the cutoff line for a positive C6 ELISA.
Histopathologic Evaluation, FJC Staining for
Neurodegeneration, and Luxol-Fast Blue Staining
for Demyelination
Tissues that were collected from various regions of the brain,
spinal cord, and DRG at necropsy and ﬁxed in formalin or
Z-ﬁxative (Anatech, Battle Creek,MI)were sectioned at 5-mm
thickness and processed for hematoxylin and eosin staining
for routine histopathologic evaluation.40 Tissues ﬁxed in
Z-ﬁxative were also used for evaluation of neurodegeneration.
This was performed in tissue sections cut at a thickness of 5
mm, using the Fluoro-Jade C (FJC) ready-to-dilute staining kit
(Biosensis, Thebarton, SA, Australia) as per the manufac-
turer’s instructions. FJC is able to identify degenerating
neurons.41,42 Its application was followed by immunoﬂuo-
rescence stainingwith the nuclear stain TOPRO3 (Invitrogen).
The slides were then air-dried and coverslipped with a
nonaqueous, low-ﬂuorescence, styrene-based mounting
medium, DPX (Sigma-Aldrich). Formalin-ﬁxed tissues cut at
5-mm thickness were used to detect demyelination after
hematoxylin and eosin staining, in addition to the Luxol
Fast Blueeperiodic acid-Schiffehematoxylin combination
method.43,44
Determination of Phenotypes of Producer Cells,
Intracytoplasmic Localization of Immune Mediators,
and Detection of Cells in Inﬂammatory Lesions and
Bb Antigen in DRG
To determine the phenotypes of producer cells and to detect
intracytoplasmic localization of immune mediators, fresh
tissues were collected from the DRG at necropsy and
immediately processed for blocking of intracytoplasmic
cytokines, followed by ﬁxation in 2% paraformaldehyde, as
previously described.45 They were then cryopreserved after
cryosectioning into 16-mm sections. DRG tissue collected at
necropsy, ﬁxed in formalin (Z-ﬁxative), and sectioned into
10-mm sections was used for the detection of Bb antigen and
for the characterization of phenotypes of cells in inﬂam-
matory lesions.
Formalin-ﬁxed tissues were subjected to antigen retrieval
(Vector Laboratories, Burlingame, CA) before immunoﬂuo-
rescence staining. Sections were subjected to immunoﬂuores-
cence staining by using combinations of primary antibodies
listed in the next paragraph and corresponding secondary anti-
bodies diluted in 10% normal goat serum, as previously
described.46Relevant isotype controls at the concentrationof the
corresponding primarymonoclonal antibodies (Sigma-Aldrich)
and universal rabbit immunoglobulin-negative controls forajp.amjpathol.org - The American Journal of Pathology
Pathogenesis of Lyme Neuroborreliosisrabbit polyclonal antibodies (Dako Cytomation, Carpinteria,
CA) were also included.
The anti-immune mediator primary antibodies used
included anti-human IL-6, mouse IgG2a (ProSpec, Ness
Ziona, Israel) at 1:1000; anti-human CCL2, rabbit polyclonal
IgG clone ab7814 (Abcam, Cambridge, MA) at 1:50; or anti-
human IL-8, polyclonal rabbit IgG (ResearchDiagnostics Inc.,
Flanders, NJ) at 10 mg/mL The primary antibodies against
various phenotypic markers of cells used were anti-human
2,30-cyclic nucleotide 30-phosphodiesterase (CNPase), clone
11-5B mouse IgG1 (Millipore) at 10 mg/mL; anti-human S-
100 (Sigma-Aldrich) at 1:500; anti-human neuronal nuclear
protein (NeuN),MAB377cloneA60,mouse IgG1 (Millipore)
at 1:10; anti-human CD3 polyclonal rabbit IgG (Biocare,
Concord, CA) at 1:200; anti-human CD20 clone L29, mouse
IgG2a (Dako Cytomation) at 1:200; and anti-human CD68
clone KP1, mouse IgG1 at 1:50 (Dako Cytomation). Bb was
stained with a rabbit polyclonal antibody against whole
Borrelia (Accurate Chemicals, Westbury, NY) at 1:200.
After completion of immunoﬂuorescence staining, slides
were mounted in antiquenching agent (Sigma-Aldrich) and
stored at 4C until viewed on a confocal microscope (see
Confocal Microscopy). A total of three cryosections per
block of DRG tissue were evaluated per rhesus macaques
for the detection of intracytoplasmic immune mediators,
phenotypes of producer cells and phenotypic markers of
cells in inﬂammatory lesions and for the detection of Bb
antigen from formalin-ﬁxed tissues, respectively.
Qualitative and Quantitative Assessment of Glial and
Neuronal Apoptosis in the DRG
Glial and neuronal apoptosis by the in situ terminal deox-
ynucleotidyl transferase-mediated dUTP nick-end labeling
(TUNEL) assay was assessed by immunoﬂuorescence
staining in tissues collected from the DRG. Tissues were
directly ﬁxed in 2% paraformaldehyde and cryopreserved
and frozen as previously described.46 Sections were stained
for any one of the following cell markers: NeuN, S-100, or
CNPase by incubation with the appropriate primary anti-
bodies at concentrations described in the section above,
followed by secondary antibodies conjugated with Alexa
Flour 568 (Invitrogen). Sections were re-ﬁxed in 2% para-
formaldehyde for 15 minutes and then subjected to the
TUNEL-ApopTagPlus ﬂuorescein in situ apoptosis assay
(Millipore) as per the manufacturer’s instructions. Apoptosis
was also evaluated by immunoﬂuorescence staining for
activated caspase-3 (AC-3), rabbit polyclonal to AC-3, clone
antibody 13,847 (Abcam) at a concentration of 5 mg/mL
diluted in normal goat serum followed by secondary antibody,
anti-rabbit IgG conjugated to Alexa Fluor 488 (Invitrogen),
in combination with antibodies to the neuronal marker NeuN
and the myelinating-cell marker CNPase. Slides were ﬁnally
stained with nuclear stain TOPRO3 (Invitrogen) at 1:1000 in
normal goat serum for 15 minutes. Slides were washed and
mounted as described above and stored at 4C in the dark untilThe American Journal of Pathology - ajp.amjpathol.orgviewed. The percentage of apoptotic cells from 10 ﬁelds were
counted in each of the sections (>500 cells in all cases). The
total number of NeuN- or S-100epositive cells, respectively,
in each section was ascertained, followed by the percentage of
cells that colocalized with the TUNEL signal for each cell
marker. Similarly, the percentage of NeuN staining sensory
neurons that expressed AC-3 in the DRG of all rhesus
macaques was quantiﬁed. All counts were made by viewing
slides under a ﬁxed magniﬁcation of 40 for evaluation of
apoptosis by TUNEL assay for neurons and satellite glial cells
and at20 for evaluation of neurons that express AC-3 in the
DRG of all rhesus macaques, using a confocal microscope
(see the next section).
Confocal Microscopy
Confocal microscopy was performed with a Leica TCS SP2
confocal microscope (Leica Microsystems, Exton, PA) as
previously described.46 Photoshop CS3 (Adobe Systems
Inc., San Jose, CA) was used for image processing.
NCSs and Evaluation of F-Wave Chronodispersion
NCSs were performed on rhesus macaques anesthetized with
ketamine hydrochloride (10 mg/kg intramuscularly), supple-
mented with isoﬂuorane by inhalation as needed. Sterile sub-
dermal Nicolet electrodes (CareFusion, San Diego, CA) were
used as recording electrodes, and cathodal surface stimulation
was used for nerve excitation. For motor NCSs, recording
electrodeswere placed over the appropriatemuscle in the hand
or foot, and the nerve was stimulated at distal and proximal
sites.Median, ulnar, and tibialmotor responseswere recorded,
and conduction velocity was calculated. F waves were elicited
at rest by antidromic supramaximal stimulation over the distal
nerve and recording from the same muscles as in the motor
NCSs.47,48 A minimum of 30 F waves were recorded, and the
minimal latency, maximal latency, and the difference between
the minimal and maximal latencies (chronodispersion) were
measured. For median and ulnar sensory NCSs, recording
electrodes were placed over the nerve at the wrist, and sensory
nerve ﬁbers were stimulated orthodromically with digital ring
electrodes. All procedures were done on a Viking Select
electromyographic system (Cardinal Health Systems, Dublin,
OH). Limb temperature was maintained at higher than 34C
with the use of a heating lamp.
Statistical Analysis
The statistical signiﬁcance of the data for pleocytosis and
immune mediators in CSF and serum was calculated with
the two-way analysis of variance, followed by the Bonfer-
roni post tests, and that of the apoptosis data were evaluated
by Kruskal-Wallis one-way analysis of variance nonpara-
metric analysis, followed by the Dunn’s multiple compari-
son test by using Prism software version 5 (GraphPad
Software, Inc., La Jolla, CA).1347
Table 1 CSF Cell Pellet Culture Results for Viable Bb from CSF Collected from Rhesus Macaques Inoculated Intrathecally with Live Bb and
Left Untreated or Treated in Parallel with Either Dex or Mel
Rhesus macaques
and treatments Week 0 Week 1 Week 2 Week 3 Week 4 Week 6 Week 8 Week 10 Week 12 Week 14 At necropsy
GN22 (Bb alone)   þ  þ   NA NA NA 
GB09 (BbþDex)  þ  þ  þ  NA NA NA 
GP33 (BbþMel)  þ þ     NA NA NA 
GN21 (Bb alone)   þ   þ þ NA NA NA þ
IG55 (BbþDex)   þ     NA NA NA 
HH83 (BbþMel)  þ    þ  NA NA NA þ
IK20 (control)        NA NA NA 
GC59 (Bb alone)  þ   þ     þ þ
GJ23 (BbþDex)  þ þ        þ
GK54 (BbþMel)  þ þ þ      þ þ
HT72 (Bb alone)  þ þ        
GM23 (BbþDex)  þ  þ       
GN49 (BbþMel)  þ   þ þ     
HT73 (control)           
Bb, Borrelia burgdorferi; CSF, cerebral spinal ﬂuid; Dex, dexamethasone; Mel, meloxicam; NA, not applicable.
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Establishment of Persistent CNS Infection as a Result
of Intrathecal Inoculation with Live Bb
Culture of cell pellets from CSF collected at various time
points after inoculation yielded viable spirochetes at 1
time points for all of the rhesus macaques that were inoc-
ulated with Bb regardless of whether they were left un-
treated (Bb alone), treated with Dex (BbþDex), or treated
with Mel (BbþMel), as shown in Table 1. The occipital lobe
of animal GB09 (BbþDex 8 weeks), cervical and lumbar
spinal cord of animal HH83 (BbþMel 8 weeks), brainstem
of GJ23 (BbþDex 14 weeks), cervical and thoracic spinal
cord of GK54 (BbþMel 14 weeks), and the sacral spinal
cord of HT72 (Bb alone) yielded positive cultures for viable
spirochetes when cultured after necropsy. Cultures of CSF
pellets and necropsy tissues of control rhesus macaques
were negative throughout.Figure 1 Dex signiﬁcantly reduces CSF pleocytosis elicited by Bb. WBCs per
thecally with live Bb alone, inoculated with Bb and treated with Dex, inoculated
weeks (A) and 14 weeks (B) after inoculation. Data are expressed as means  SD.
Bb alone, determined by two-way analysis of variance, Bonferroni post tests. B
meloxicam; WBC, white blood cell.
1348Dexamethasone Treatment Results in More Signiﬁcant
Reduction in CSF Pleocytosis as Induced by Intrathecal
Inoculation of Live Bb Compared with Meloxicam
Intrathecal inoculation of live Bb into the cisterna magna of
rhesus macaques resulted in CSF pleocytosis as evidenced
by increased numbers of white blood cells per microliter of
CSF, as early as 1 week after inoculation. The pleocytosis
was primarily lymphocytic and monocytic in nature (not
shown), as reported earlier.35 Dexamethasone-treated rhesus
macaques showed signiﬁcant reduction in pleocytosis,
compared with that present in infected rhesus macaques that
were left untreated, whereas infected rhesus macaques that
were treated with Mel showed similar albeit slightly lower
levels of pleocytosis to that of the infected untreated rhesus
macaques. Specimens from uninfected controls were
essentially free of cells. Similar patterns of pleocytosis were
seen in both treatment groups (8 weeks and 14 weeks)
(Figure 1).microliter of CSF recorded over time in rhesus macaques inoculated intra-
with Bb and treated with Mel, and uninfected controls were followed for 8
nZ 2 rhesus macaques. ***P < 0.001 for the comparison of BbþDex with
b, Borrelia burgdorferi; CSF, cerebrospinal ﬂuid; Dex, dexamethasone; Mel,
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Figure 2 Effect of Dex and Mel on levels of CSF
immune mediators as induced by Bb. Levels of CSF
IL-6 (A and B), IL-8 (C and D), CCL2 (E and F), and
CXCL-13 (G and H) in rhesus macaques inoculated
intrathecally with live Bb alone, inoculated with
Bb and treated with Dex, inoculated with Bb and
treated with Mel, and uninfected controls were
followed for 8 weeks (A, C, E, and G) and 14 weeks
(B, D, F, and H) after inoculation. Data are
expressed as means  SD. nZ 2 rhesus macaques.
*P < 0.05 for the comparison of BbþDex with Bb
alone, determined by two-way analysis of variance,
Bonferroni post-tests. Bb, Borrelia burgdorferi;
CCL2, chemokine ligand 2; CSF, cerebrospinal ﬂuid;
Dex, dexamethasone; Mel, meloxicam.
Pathogenesis of Lyme NeuroborreliosisEffect of Treatment with the Anti-Inﬂammatory Drugs
Dex and Mel on the Levels of Immune Mediators in the
CSF and Serum as Induced by Intrathecal Inoculation
of Live Bb
Several of the tested immune mediators were up-regulated in
the CSF of the rhesus macaques that were inoculated intra-
thecally with Bb. These were IL-6, IL-8, CCL2, and
CXCL13. The concentrations of IL-6 and IL-8 peaked by
week 1 after inoculation. Levels of CCL2 and CXCL13
peaked somewhat later, between weeks 1 and 2 after inocu-
lation for CCL2 and between weeks 1 and 3 after inoculation
for CXCL13. Peak values for the untreated Bb-inoculated
rhesus macaques also differed among mediators, with low
levels for IL-6 (20 to 25 pg/mL) and IL-8 (70 pg/mL) andThe American Journal of Pathology - ajp.amjpathol.orghigher levels for CCL2 (700 to 800 pg/mL) and CXCL13
(1500 to 2000 pg/mL). Interestingly, peak mediator con-
centrations were signiﬁcantly diminished when the rhesus
macaques were treated with Dex but not with Mel (P < 0.05
two-way analysis of variance, Bonferroni post tests). The
only exception was CXCL13, whose concentration also
diminished signiﬁcantly in Mel-treated rhesus macaques.
The concentration of mediators in the CSF of control rhesus
macaques was undetectable expect in the cases in which there
was constitutive production, namely, CCL2 and IL-8. In
addition, one of the controls produced low levels of consti-
tutive IL-6. All of these patterns were similar in both treat-
ment groups (8 weeks and 14 weeks) (Figure 2).
As with CSF, the inﬂammatory mediators CCL2,
CXCL13, and IL-8 were also elevated in the serum, but their1349
Figure 3 Inﬂammatory lesions in the brain
and spinal cord in Bb-inoculated rhesus macaques.
Representative images of inﬂammatory lesions
were observed by H&E histopathologic evaluation
of brain and spinal cord at necropsy of rhesus
macaques that received an intrathecal inoculation
of live Bb alone and those inoculated with Bb and
treated with Mel show leptomeningitis in the spi-
nal cord with Bb alone at 8 weeks (A), cranial
nerve neuritis with Bb alone at 8 weeks (B),
vasculitis in the brainstem with BbþMel at 8 weeks
(C), focal degeneration and necrotizing myelitis in
the cervical spinal cord with Bb alone at 14 weeks
(D), and absence of inﬂammation in the lep-
tomeninges of the cervical spinal cord with
BbþDex at 8 weeks (E). Scale bar Z 50 mm. Bb,
Borrelia burgdorferi; Dex, dexamethasone; H&E,
hematoxylin and eosin; Mel, meloxicam.
Ramesh et alconcentrations peaked later (around 4 weeks after inocula-
tion), except in animal HT72 (Bb alone 14 weeks) in which
anti-VlsE (C6) antibody levels (described below) were
undetectable throughout the duration of the study. IL-6, in
contrast, was undetectable in the serum of all rhesus
macaques in the study at all times. Additional mediators that
were elevated in serum were IL-12, CD40L, IL-18, IL-15,
and TGF-a, also reaching peak values at approximately 4
weeks after inoculation. The concentrations of all but one of
the mediators that were elevated in infected/untreated rhesus
macaques were reduced to baseline values or below by
treatment with Dex. The exception was TGF-a, whose
concentration was enhanced by Dex above the value that
was observed in infected/untreated rhesus macaques.
Treatment with Mel signiﬁcantly diminished the concen-
trations of CXCL13 and CD40L but left that of the other
mediators unchanged for the values observed in infected/
untreated rhesus macaques (data not shown).
Evidence of Anti-VlsE (C6) Antibody in Serum
We evaluated the appearance of anti-VlsE (C6) antibodies
in the serum to assess if the infection had become sys-
temic. All rhesus macaques that were infected with Bb and1350left untreated except HT72 (Bb alone 14 weeks) and all
infected rhesus macaques that were treated with Mel
showed the presence of detectable anti-VlsE (C6) anti-
bodies from week 3 after inoculation, but no detectable
levels of anti-VlsE (C6) antibodies were found in the
uninfected controls and rhesus macaques that were
infected but treated with Dex, except IG55 (BbþDex 8
weeks; data not shown).Differential Histopathologic Evidence of Inﬂammation
in the Brain and Spinal Cord Regions in Infected
Untreated versus Treated Rhesus Macaques
Histopathologic evaluation after hematoxylin and eosin
staining40 for inﬂammation in tissue from rhesus macaques
at necropsy of all rhesus macaques that received intrathecal
inoculation of only live Bb and those that were inoculated
and treated with Mel revealed lesions typical of lymphocytic
meningitis in the brain and spinal cord and lymphocytic
neuritis and ganglionitis in random sections of the spinal
cord. No lymphocytic inﬂammatory lesions were seen in the
brain and spinal cord of rhesus macaques that were inocu-
lated with live Bb and treated with Dex or in the un-ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Radiculitis in Bb-inoculated rhesus
macaques. Inﬂammatory lesions observed by H&E
histopathologic evaluation of spinal nerve roots
and DRG at necropsy of animals that received an
intrathecal inoculation of live Bb alone and ani-
mals inoculated with Bb and treated with Mel,
showing radiculitis in the dorsal root of the cer-
vical spinal cord at C7 with Bb alone at 8 weeks
(A), in the ventral spinal root (B), DRG inﬂam-
mation of the C6 cervical region with Bb alone at
14 weeks (C), DRG neuritis as seen in the nerve
adjacent to the C8 cervical DRG with Bb alone at 8
weeks (D), radiculitis in the dorsal root of the
cervical spinal cord at C7 with BbþMel at 8 weeks
(E), and the absence of inﬂammatory lesions in the
DRG and dorsal root of the C8 cervical region with
BbþDex at 8 weeks (F). Scale bar Z 50 mm. Bb,
Borrelia burgdorferi; Dex, dexamethasone; DRG,
dorsal root ganglia; H&E, hematoxylin and eosin;
Mel, meloxicam.
Pathogenesis of Lyme Neuroborreliosisinoculated controls. Two rhesus macaques (one in the Bb
alone group and one in the BbþDex group) had segmental
lesions either in the brainstem or proximal cervical cord
characterized by focal malacia, nerve ﬁber degeneration,
and accumulation of enlarged phagocytic cells that consisted
of distended granular cytoplasm.
Lymphocytic meningitis was observed in the dura mater in
the brain and leptomeningitis was present in the spinal cord of
all of the infected rhesus macaques except those that were
treated with Dex. Leptomeningitis in the cervical spinal cord
showed large perivascular inﬁltrates of mononuclear cells
around blood vessels in the subarachnoid space, involving
both the pia mater and arachnoid (Figure 3A). Cranial nerve
neuritis showed immune cell inﬁltrates that consisted of small
lymphocytes and a few larger histiocytic cells under the
epineurium or connective tissue surrounding the nerve
(Figure 3B). Vasculitis was present in the brainstem of all of
the infected rhesus macaques except those treated with Dex,
with lymphocytic inﬁltrates in the vessel walls (Figure 3C).
Necrotizing myelitis and degeneration was observed in the
cervical spinal cord of two rhesus macaques (Figure 3D).
Severe degeneration and necrotizing myelitis near the injec-
tion site were histologically different from the lymphocyticThe American Journal of Pathology - ajp.amjpathol.orginﬂammatory lesions that could be found all the way along the
spinal cord to the sacral region of all of the infected rhesus
macaques except those treated with Dex. A representative
image of the absence of inﬂammatory lesions in the lep-
tomeninges of the cervical spinal cord of BbþDex rhesus
macaques is shown in Figure 3E.
Evidence of Radiculitis in All Infected Rhesus
Macaques but Those Treated with Dexamethasone
Radiculitis or inﬂammation in the dorsal (sensory) and ventral
(motor) spinal roots affected nerve roots on both sides of the
spinal cord that spanned the entire cervical region and occa-
sionally in the thoracic region, in addition to inﬂammation and
neuritis in the DRG in all of the rhesus macaques that were
inoculated with Bb and left untreated and those rhesus ma-
caques inoculated with Bb and treated with Mel. Lesions
of radiculitis or DRG inﬂammation and DRG neuritis were
absent in the rhesus macaques inoculated with live Bb and
treated with Dex, as well as in the uninoculated controls
(Figure 4). Dorsal root radiculitis in the cervical spinal cord,
with lymphoid cell inﬁltration, and linear clear spaces around
nerve ﬁbers that are indicative of nerve ﬁber swelling and1351
Figure 5 Bb antigen and inﬂammatory cells in the DRG of Bb-inoculated rhesus macaques. A: Confocal micrographs show the presence of Bb antigen in the
DRG after immunoﬂuorescence staining with a Borrelia-speciﬁc antibody (Bb). B: Confocal micrographs shown in the same staining applied to DRG of an
uninfected control rhesus macaque. C: No ﬂuorescence signal is observed when a DRG section from a Bb-infected rhesus macaque was stained with the relevant
isotype control, followed by the corresponding secondary antibody tagged to Alexa Fluor 488. Nuclei of all cells appear blue due to staining with nuclear stain
TOPRO3. Neurons appear red due to immunoﬂuorescence staining with NeuN stain, followed by corresponding secondary antibody tagged to Alexa Fluor 568.
D: A confocal microscopic image of a lesion in the dorsal root of a Bb-infected rhesus macaque shows the presence of abundant T lymphocytes that express CD3
(green), macrophages that express CD68 (red), and B lymphocytes that express CD20 (blue) after immunoﬂuorescence staining. Unstained tissue appears gray
due to differential interference contrast imaging. Bb, Borrelia burgdorferi; DIC, differential interference contrast; DRG, dorsal root ganglia; NeuN, neuronal
nuclear protein.
Ramesh et alpossible demyelination were observed (Figure 4A). Radiculitis
was observed in the ventral spinal root with lymphoid in-
ﬁltrates (Figure 4B). Inﬂammation was present in the cervical
DRG with dying neuronal cell bodies and accumulation of
inﬁltrating lymphoid mononuclear cells (Figure 4C). The
presence of neurodegeneration in sensory neurons and areas
corresponding to the dorsal roots that traverse the DRG (green)
in an adjacent section was conﬁrmed by FJC staining (see
Evidence of Neurodegeneration). Figure 4D shows a repre-
sentative image of DRG neuritis, with inﬂammation between
the nerve ﬁbers in a nerve root that is immediately adjacent to
the DRG of the C8 cervical region. A representative image of
radiculitis in the dorsal root of the cervical spinal cord at C7 of
infected rhesusmacaques treated withMel at 8 weeks is shown
in Figure 4E. The absence of inﬂammatory cell inﬁltrates in the
DRG and dorsal root of the C8 cervical region of infected
rhesus macaques treated with Dex is shown in Figure 4F.1352Detection of Bb Antigen and Characterization of Cell
Phenotypes in Inﬂammatory Lesions in the DRG
Immunoﬂuorescence staining and confocal microscopic
evaluation of DRG tissues collected at necropsy revealed the
presence of similar amounts of Bb antigen in the DRG of all
of the infected rhesus macaques, including those treated with
Dex. Bb antigens were present after immunoﬂuorescence
staining by using a polyclonal rabbit anti-Bb antibody, fol-
lowed by the corresponding secondary antibody tagged with
Alexa Fluor 488 in the DRG (Figure 5A). Antigen was
localized in the spaces between the neurons. These cells appear
red due to immunoﬂuorescence staining with NeuN, a speciﬁc
neuronal marker.49 Antigen was also present in the region that
corresponded to the dorsal root traversing the DRG. Nuclei of
all cells appear blue due to stainingwith TOPRO3. Spirochetal
antigen was undetectable in DRG tissues from uninfectedajp.amjpathol.org - The American Journal of Pathology
Figure 6 Demyelination in nerve roots of Bb-inoculated rhesus ma-
caques. Demyelination in the cervical dorsal root at C6 with BbþMel at 14
weeks made evident by H&E stain, showing loss of normal eosinophilic
myelin coat in a nerve bundle that appears gray in contrast to normally
myelinated nerves that appear pink. Scale bar Z 50 mm. Bb, Borrelia
burgdorferi; H&E, hematoxylin and eosin; Mel, meloxicam.
Pathogenesis of Lyme Neuroborreliosiscontrols (Figure 5B). No green ﬂuorescence staining was
observed when universal rabbit IgG isotype control was used
instead of the anti-Bb antibody, followed by the relevant
secondary antibody tagged to Alexa Fluor 488 (Figure 5C).
Phenotypic characterization of cells in an inﬂammatory
lesion from the dorsal roots of rhesus macaques that were
infected with live Bb alone and those infected with Bb and
treated with Mel, showed the presence of abundant lym-
phocytes and monocytes. Figure 5D depicts a representative
image of a lesion in the dorsal root after immunoﬂuores-
cence staining and confocal microscopic imaging that show
abundant CD3-expressing T cells,50 CD68-expressing
macrophages,51 and B cells that express CD2052
Demyelination in Spinal Nerve Roots
Demyelination was evident in the spinal nerve roots of all of
the infected rhesus macaques except those treated with Dex
and the uninfected controls (Figure 6).40 There was loss of
the normal eosinophilic myelin coat in a bundle of nerve
ﬁbers in a cervical dorsal root. Residual Schwann cell nuclei
appeared more pronounced because of loss of myelin.
Demyelination was visualized in a dorsal root after
staining with Luxol-Fast Blue/periodic acid-Schiff combi-
nation stain43,44 (Supplemental Figure S1).
Qualitative and Quantitative Assessment of Glial and
Neuronal Apoptosis in the DRG
We had previously observed neuronal and satellite cell
apoptosis in DRG of rhesus macaques that were inoculated
intrathecally with live Bb.35 We therefore evaluated the
levels of apoptosis of these cells and Schwann cells in the
DRG of rhesus macaques in this study, to ascertain if
inﬂammation had a possible causal role in mediatingThe American Journal of Pathology - ajp.amjpathol.orgapoptosis, as induced by Bb. The evaluation was done both
qualitatively and quantitatively by using the in situ TUNEL
assay53 and by immunoﬂuorescence staining for AC-3,54
under the confocal microscope. Neuronal apoptosis in the
DRG (Bb alone 14 weeks) was observed (Figure 7A). Neu-
rons were labeled with antibody to NeuN, followed by the
corresponding secondary antibody tagged to Alexa Fluor
568. Apoptotic neurons that expressed AC-3 showed coloc-
alization with NeuN. AC-3 was also present in the area
occupied by satellite glial cells around the neurons in the
DRG and in the Schwann cells stained with the myelin
marker CNPase55 in the dorsal roots within the DRG (not
shown). The percentage of neuronal cells that showed AC-3
in the DRG for all of the rhesus macaques was calculated
(Figure 7B). Dexamethasone treatment signiﬁcantly reduced
the percentage of neuronal cells that expressed AC-3 after 8
weeks of treatment (6.7% 0.5%; P< 0.05, Kruskal-Wallis
test, one-way analysis of variance, Dunn’s multiple com-
parison test) and after 14 weeks of treatment (9.3%  0.5%;
P < 0.001) compared with infected rhesus macaques that
were left untreated for 8 weeks (15.84%  0.89%) and 14
weeks (21.80%  1.86%). Meloxicam treatment for both 8
weeks (21.54%  0.82%) and 14 weeks (26.72%  1.16%)
showed levels of neuronal apoptosis that were similar or
slightly higher than those induced by Bb infection alone.
Basal levels of neuronal apoptosis were found in the control
rhesus macaques after 8 weeks (3.9%  0.13%) and 14
weeks (5.13%  0.53%).
DRG cell apoptosis was evaluated qualitatively by the
TUNEL assay (Figure 7C). The positive TUNEL signal was
evident in the nuclei of satellite glial cells that surround the
sensory neurons. Abundant apoptotic cells in the area cor-
responding to the dorsal root (possibly Schwann cells) that
traverses the DRG were observed (Figure 7D). The per-
centage of neurons undergoing apoptosis in the DRG for all
of the rhesus macaques in the study was quantiﬁed by the
TUNEL assay (Figure 7E). Intrathecal inoculation of live
Bb resulted in a fraction of apoptotic cells of 8.4%  0.4%
after 8 weeks and 9.5%  0.6% after 14 weeks after inoc-
ulation, compared with basal levels of 2.2%  0.3% (8
weeks) and 2.7%  0.2% (14 weeks) after inoculation.
Dexamethasone treatment signiﬁcantly reduced neuronal
apoptosis as visualized by the TUNEL assay both at 8 weeks
(1.46%  0.3%) and 14 weeks (2.6%  0.13%) after inoc-
ulation, whereas Mel treatment resulted in levels that were
similar or slightly higher than those seen in infected rhesus
macaques that were left untreated, reaching 8.01%  0.5% at
8 weeks and 11.88%  0.4% at 14 weeks after inoculation.
We used the marker S-100 to stain glial cells in the DRG
and evaluated the percentage of satellite glial cells undergo-
ing apoptosis by the TUNEL assay by counting the S-100e
positive cells immediately surrounding the sensory neurons,
as reported earlier35 (Figure 7F). Neuronal apoptosis was
evaluated quantitatively by the TUNEL assay in satellite glial
cells in all of the rhesus macaques in the study (Figure 7G). A
basal level of 5% apoptosis was found in the uninfected1353
Figure 7 Glial and neuronal apoptosis in the DRG. A: A confocal image of DRG neuron apoptosis as visualized by immunoﬂuorescence staining for AC-3
(green). Neurons appear red due to immunoﬂuorescence staining for NeuN (Bb alone at 14 weeks). Apoptotic neurons that express AC-3 appear orange due
to colocalization of the red (NeuN) and green (AC-3) signals. Nuclei of all cells appear blue due to staining with nuclear stain TOPRO3. B: Neuronal apoptosis
as evaluated quantitatively by the AC-3 immunoﬂuorescence assay in all of the rhesus macaques in the study (inoculated intrathecally with live Bb alone,
inoculated with Bb and treated with Dex, inoculated with Bb and treated with Mel, and uninfected controls for both 8 weeks and 14 weeks after inocu-
lation). C: A confocal image of DRG neuronal apoptosis as visualized by the TUNEL assay (Bb alone at 14 weeks). Neurons appear red due to immuno-
ﬂuorescence staining for NeuN, whereas TUNEL signal showing apoptotic nuclei appears green. Nuclei of all cells appear blue due to staining with nuclear
stain TOPRO3. D: A representative confocal image showing abundant TUNELþ nuclei in the dorsal region (Bb alone at 14 weeks). Neurons appear red due to
immunoﬂuorescence staining for NeuN, and nuclei of all cells appear blue due to staining with nuclear stain TOPRO3. E: A quantitative representation of
neuronal apoptosis as evaluated by the TUNEL assay in all of the rhesus macaques in the study. F: A confocal image of satellite glial cells (red) after
immunoﬂuorescence staining for S-100 and TUNELþ nuclei in green. G: A quantitative representation of satellite glial cell apoptosis as evaluated by the
TUNEL assay in all of the rhesus macaques in the study. Data are expressed as means  SEM of animals in each treatment group. nZ 2 rhesus macaques.
*P < 0.05, **P < 0.01, and ***P < 0.001 determined by Kruskal-Wallis test, one-way analysis of variance, Dunn’s multiple comparison test. AC-3, active
caspase-3; Bb, Borrelia burgdorferi; Dex, dexamethasone; DRG, dorsal root ganglia; Mel, meloxicam; NeuN, neuronal nuclear protein; TUNEL, terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling.
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Figure 8 Neurodegeneration in inﬂamed DRG. Confocal microscope
image of degenerating neurons (green) as stained by FJC in the DRG (Bb
alone at 14 weeks) showing degenerating neuronal axons in a dorsal root,
adjacent to the DRG are also seen to stain green with FJC. Nuclei of all cells
appear blue due to staining with nuclear stain TOPRO3 (A), neuro-
degeneration in the DRG and dorsal root entering the DRG with BbþMel at
14 weeks (B), absence of neurodegeneration in an uninfected control
rhesus macaque at 8 weeks (C), and presence of degenerating neurons in
the DRG and areas corresponding to the dorsal roots that traverse the DRG
in a section parallel to that showing neurodegeneration as seen with Bb
alone at 14 weeks in Figure 4C (D). Bb, Borrelia burgdorferi; DRG, dorsal root
ganglia; FJC, Fluoro-Jade C; Mel, meloxicam.
Pathogenesis of Lyme Neuroborreliosiscontrols both at 8 and 14 weeks after inoculation. Intrathecal
inoculation of live Bb resulted in 15.05%  0.6% of satellite
glial cell apoptosis after 8 weeks and 15.05%  0.7% of
satellite glial cell apoptosis after 14 weeks after inoculation.
Dexamethasone treatment was effective in signiﬁcantly
reducing neuronal apoptosis to 7.1%  1.2% (8 weeks) and
3.7%  0.2% in the Bb-infected rhesus macaques that were
treated with Dex for 14 weeks after inoculation. The percent-
age of TUNEL-positive satellite glial cells in the infected
rhesus macaques that were treated with Mel was
16.63%  0.44% (8 weeks) but showed only 9.12%  1.3%
apoptosis in infected rhesus macaques that were treated with
Mel for 14 weeks after inoculation, suggesting that the drug
was effective in protecting against satellite glial cell apoptosis
with prolonged treatment. In summary, Dex treatment was
effective in protecting both satellite glial cell and neuronal
apoptosis induced by Bb, as evaluated by the AC-3 and the
TUNEL assays, whereas Mel treatment was only effective in
protecting against satellite glial cell apoptosis after prolonged
treatment after inoculation of 14 weeks.
Evidence of Neurodegeneration
We conﬁrmed the presence of dying neurons that we found in
the DRG by staining with FJC sections of tissues from theThe American Journal of Pathology - ajp.amjpathol.orgDRG and dorsal roots of all of the rhesus macaques. This
anionic reagent has an afﬁnity for degenerating neurons,
which are supposed to express a basic or positive charge.41,42
The FJC stain is known to selectively label degenerating
neurons in addition to certain non-neuronal elements such as
the meninges and blood vessels, as was evident in the
capsular area of the DRG41 (Figure 8A). The degenerating
neuronal axons in a dorsal root entering the DRG in addition
to degenerating neurons in the DRG of an infected rhesus
macaque that was also treated with Mel (BbþMel 14 weeks)
is shown in Figure 8B. Degenerating neurons were not
detected in the DRG and axons of nerve roots from rhesus
macaques that were inoculated with live Bb but treated with
Dex (not shown). The uninfected control rhesus macaques
showed an absence of neurodegeneration after FJC staining
(Figure 8C). Neurodegeneration in a section of DRG (Bb
alone 14 weeks) from an adjacent section to that shown in
Figure 4C, showing the presence of neurodegeneration in
sensory neurons and areas that correspond to the dorsal roots
that traverse the DRG as conﬁrmed by FJC staining, is shown
in Figure 8D.
CCL2 in the Dorsal Root Ganglia of Bb-Inoculated
Rhesus Macaques
CCL2 in sensory neurons and in the region that corresponds to
satellite glial cells in aDRG (Bbalone14weeks) (Supplemental
Figure S2A), satellite glial cells that surround the sensory neu-
rons (Supplemental Figure S2B), and Schwann cells
(Supplemental Figure S2C) were observed.
Electrophysiologic Evidence of Abnormal F
Waves/Chronodispersion in Nerve Roots of Rhesus
Macaques Inoculated Intrathecally with Live Bb
We had previously observed perivascular inﬂammatory
inﬁltrates and multifocal axonal changes that were consis-
tent with mononeuropathy multiplex in rhesus macaques
infected with Bb.32 Moreover, an association between
demyelinating neuropathy and abnormal temporal disper-
sion and nerve conduction slowing was described in a few
case reports of human LNB.17 We therefore performed
NCSs in motor nerves (median, ulnar, and tibial) on the
right side and sensory nerves (median and ulnar) bilaterally
to explore the C8/T1 nerve roots in the upper limbs and S1
in the lower limb. Most marked abnormalities were found in
F-wave latencies recorded 2 weeks after inoculation, in
rhesus macaques infected with Bb alone (GN22 Bb alone 8
weeks, HT72 Bb alone 14 weeks) that remained abnormal
until the end of the study. Some of the rhesus macaques
infected with Bb in the presence of Mel (GK54, GN49)
showed more marked increased F-wave latencies and
chronodispersion than that seen in rhesus macaques infected
with Bb alone by week 2 after inoculation and persisted
until 14 weeks after inoculation, the end of the study. Only
one of the four rhesus macaques that were infected and1355
Table 2 F-Wave Latencies Recorded for Motor Nerves (Median, Ulnar, and Tibial) in Rhesus Macaques Inoculated Intrathecally with Live Bb
and Left Untreated or Treated with Either Dex or Mel
Rhesus macaques and treatment F-wave latencies (msec)
GN22 (Bb alone 8 weeks) Abnormal F waves in all nerves recorded from week 2 PI until end of study
Median F waves Z 14.8e20.2 (UL 14.7)*
Ulnar F waves Z 15.1e22.5 (UL 14.8)*
Tibial F waves Z 21.2e30.1 (UL 20.7)*
GB09 (BbþDex 8 weeks) Normal
GP33 (BbþMel 8 weeks) Normal
GN21 (Bb alone 8 weeks) Normal
IG55 (BbþDex) Normal
HH83 (BbþMel 8 weeks) Normal
IK20 (control 8 weeks) Normal
GC59 (Bb alone 14 weeks) Normal
GJ23 (BbþDex 14 weeks) Abnormal F waves in tibial nerve from week 2 PI but returned to normal by 8 weeks PI
Tibial F waves Z 17.2e25.1 at week 2; 16.5e19.6 at week 8 (UL 20.7)*
GK54 (BbþMel 14 weeks) Abnormal F waves in ulnar and tibial nerves recorded from week 2 PI until end of study
Ulnar F waves Z 16.3e24.8 (UL 14.8)*
Tibial F waves Z 22.2e33.3 (UL 20.7)*
HT72 (Bb alone 14 weeks) Abnormal F waves in median and ulnar nerves recorded from week 2 PI until end of study
Median F waves Z 15.6e22.7 (UL 14.7)*
Ulnar F waves Z 16.3e23.7 (UL 14.8)*
GM23 (BbþDex 14 weeks) Normal
GN49 (BbþMel 14 weeks) Abnormal F waves in ulnar and tibial nerves recorded from week 2 PI until end of study
Ulnar F waves Z 15.3e19.6 (UL 14.8)*
Tibial F waves Z 23.4e31.6 (UL 20.7)*
HT73 (control 14 weeks) Normal
*UL of normal in controls was based on means þ 2 SD. Unless noted, F-wave latencies were below the UL of normal.
Bb, Borrelia burgdorferi; Dex, dexamethasone; Mel, meloxicam; PI, after inoculation UL, upper limit.
Ramesh et altreated with Dex (GM23 BbþDex 14 weeks) showed a
marginal increase in F-wave latencies by 2 weeks after
inoculation that subsequently returned to normal by 8 weeks
after inoculation. Abnormalities in F-wave latencies and
chronodispersion in infected rhesus macaques, when
observed, were most likely a result of pathologic change in
motor nerve roots because more distal motor and sensory
NCSs remained normal. No electrophysiologic abnormal-
ities were recorded in any of the uninfected controls. A
summary of the results of the F-wave studies for all of the
rhesus macaques in the study is shown in Table 2.Discussion
Here, we addressed the hypothesis that inﬂammation is a
causal factor in LNB pathogenesis. To this end we made use
of intrathecal inoculation of live Bb in rhesus macaques to
facilitate the interaction of spirochetes with the CNS, a
model we had previously shown to reproduce the signs of
acute neuroborreliosis.35 Dex and Mel, two well-known
anti-inﬂammatory drugs, were used to evaluate the patho-
genetic effects of Bb-induced inﬂammation in this model.
We found that Dex treatment signiﬁcantly reduced both
pleocytosis and the levels of CSF and serum immune
mediators that were induced by Bb. Moreover, this drug
inhibited the formation of inﬂammatory lesions in the brain1356and spinal cord, focal neurodegeneration, and demyelination
in the cervical spinal cord, dorsal and ventral nerve roots, and
DRG. In contrast, all of these signs were evident in the
infected rhesus macaques that were left untreated or that were
treated with Mel. Importantly, Dex was able to signiﬁcantly
diminish the levels of neuronal and satellite glial cell
apoptosis that were induced by Bb in the DRG. Further,
persistent abnormalities in F-wave chronodispersion in nerve
roots, as evaluated by electromyographic studies, were found
only in Bb-infected rhesus macaques that were left untreated
and in those treated with the nonsteroidal anti-inﬂammatory
drug Mel, but not in rhesus macaques treated with Dex.
Thus, in accordance with our hypothesis, the effective sup-
pression of inﬂammation by Dex treatment resulted in inhi-
bition of glial and neuronal damage. These are data to suggest
that inﬂammation has a causal role in the pathogenesis of
LNB.
Intrathecal inoculation of live Bb in the cisterna magna
resulted in the establishment of a CNS infection, as evi-
denced by recovery of live spirochetes from cultures of CSF
cell pellets that were collected at one or more time points after
inoculation from all of the infected rhesus macaques and
from some CNS tissues of some of the animals, regardless of
whether the animals were left untreated or were treated with
Dex or Mel. The occurrence of pleocytosis and of increased
levels of proinﬂammatory mediators in the CSF of Bb-
infected rhesus macaques, concomitantly with the ability toajp.amjpathol.org - The American Journal of Pathology
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identify Bb antigen, including in the DRG, indicates that the
former phenomena occurred as a response to the presence of
Bb and/or Bb antigens in the CNS and PNS (DRG). Dex
signiﬁcantly inhibited Bb-induced CSF pleocytosis. This
effect was probably because of the parallel marked reduction
in the CSF concentration of chemokines that was observed in
Dex-treated rhesus macaques. Chemokines such as IL-8 and
CCL2 are known to mediate inﬂux of immune cells in the
CNS compartment during bacterial meningitis.56 IL-8 is a
neutrophil and T-cell attractant,57 and CCL2 attracts mono-
cytes and T cells58 and modulates monocyte immune func-
tions.59 Dex and Mel were both able to reduce signiﬁcantly
the levels of the B-cell chemokine CXCL13. This mediator is
the main determinant of B-cell recruitment into the CSF
during neuroinﬂammation.60
We previously reported that CCL2 and CXCL13 were
produced by spinal cord glia of rhesus macaques that were
given intrathecal inoculations with live Bb.35 In addition,
we showed that Dex could inhibit production of proin-
ﬂammatory mediators (IL-6, IL-8, and CCL2) secreted by
both oligodendrocyte and DRG cell cultures.61,62 Hence, it
is conceivable that Dex was effective in modulating the
levels of immune mediators elicited by glial cells in
response to Bb and the subsequent inﬂux of immune cells
from the periphery into the CNS.
The anti-inﬂammatory effect of Dex was also evident from
the signiﬁcantly reduced levels of the immune mediators
detected in the serum, compared with the serum levels in
infected untreated rhesus macaques. The concentration of
TGF-a, in contrast, was signiﬁcantly elevated in the presence
of Dex. This cytokine, an epidermal growth factor receptor
ligand, plays a role in the autocrine stimulation of cancer cells
in addition to a myriad other functions.63 It is not, however, a
proinﬂammatory cytokine. The observed effect, therefore,
does not contradict the general anti-inﬂammatory ability of
Dex in this experimental context. The levels of anti-VlsE
(C6) antibodies in the serum of Bb-infected rhesus ma-
caques that were treated with Dex were undetectable or low
which may be because of the ability of Dex to signiﬁcantly
affect the levels of some serum immunoglobulins.64
Mel, like Dex, was able to signiﬁcantly decrease the serum
concentrations of CD40L and CXCL13. The proinﬂam-
matory mediator CD40L was implicated in altering blood-
brain barrier integrity in HIV-associated neurocognitive
disorders.65 Serum levels of CD40L in infected untreated
rhesus macaques were as high as 20,000 pg/mL. Only Dex
was effective in signiﬁcantly reducing the serum levels of
IL-18 and CCL2, compared with the levels observed in
infected rhesus macaques that were left untreated.
An important ﬁnding of this study is that Dex treatment
was effective in curbing inﬂammation and neuro-
degeneration in the DRG and demyelination in the spinal
nerve roots. In addition, the drug signiﬁcantly reduced the
levels of Bb-induced neuronal and glial cell apoptosis in the
DRG. This result, obtained in vivo, reproduces a previousThe American Journal of Pathology - ajp.amjpathol.orgresult from our laboratory, whereby Dex signiﬁcantly
reduced apoptosis of sensory neurons in primary cultures of
rhesus DRG cells, as induced by the addition of live Bb.62
Cytokine signaling and apoptosis play a main role in
the regulation of neuroinﬂammatory responses.66e69 The
lesions of inﬂammation and neurodegeneration that we have
observed in the DRG and dorsal roots could contribute to
radiculitis and consequent neurogenic pain. The latter is the
most common presenting symptom in patients with
LNB.12,13 Sensory neurons of the DRG play a key role in
the sensation of pain,70 and the immune mediators IL-6 and
CCL2 that we found in the DRG, along with IL-8 that was
elevated in the CSF and serum of infected rhesus macaques
that were not treated with Dex, are known to increase the
sensitivity of sensory neurons to pain. They play a main role
in modulating the pain response.69e73 CCL2 is involved in
the signaling and up-regulation of several genes and pro-
teins that participate in the signal transduction of the pain
response both in the DRG and in the spinal cord.74e76
Disruption of CCL2 signaling was shown to block the
development of neuropathic pain.77 IL-6 and IL-8 can also
modulate apoptotic signaling pathways in neurons.78,79
Our electromyographic evaluations revealed that rhesus
macaques that were infected and treated with Dex showed
minimum abnormalities in F-wave chronodispersion. These
changes shortly recovered back to normal compared with
rhesus macaques that were infected with Bb and left un-
treated or treated with Mel. The latter rhesus macaques
showed higher abnormal F-wave chronodispersions, and
these persisted throughout the study period. F-wave chro-
nodispersion refers to the difference of maximal and mini-
mal latencies in a series of F waves and is highly sensitive
for diagnosing demyelinating neuropathy, whereas persis-
tence of F-wave chronodispersion is a measure of anti-
dromic excitability of a particular motor neuron pool and is
decreased in axonal neuropathy.48 Persistent abnormal
F-wave chronodispersions that were observed in this study
were localized to the nerve roots when present, suggesting
that they could be a consequence of damage to axons or
demyelination as caused by Bb. An association between
changes in the latency of F-wave frequency, abnormal
temporal dispersion, nerve conduction slowing, and the
presence of demyelinating neuropathy or axonal damage
was documented in several inﬂammatory demyelinating
peripheral neuropathic disorders, including Guillain-Barré
syndrome, and LNB.17,32,47
Importantly, we found necrotizing myelitis and degener-
ation in the spinal cord, neurodegeneration in the DRG, and
demyelination in the nerve roots only when lymphocytic
inﬂammatory lesions were also observed in both the CNS
and PNS. Ongoing cytokine activation in the nervous sys-
tem could contribute to the persistent symptoms of fatigue,
pain, and cognitive dysfunction that patients sometimes
experience despite having been treated for Lyme disease.
Our results support the hypothesis that Bb induces inﬂam-
matory mediators in glial and neuronal cells and that this1357
Ramesh et alinﬂammatory context precipitates glial and neuronal apoptosis
and an array of neurologic changes typical of LNB. Consistent
with this notionwe found that the anti-inﬂammatory drug Dex
signiﬁcantly reduced pleocytosis, inﬂammatory mediators in
the CSF, and neuronal and glial cell apoptosis in the DRG, in
addition to preventing the appearance of inﬂammatory lesions,
neurodegeneration, and demyelination. In contrast, the non-
steroidal anti-inﬂammatory drug Mel displayed a limited anti-
inﬂammatory activity that was evident chieﬂy in the reduction
of the expression levels of some cytokines and chemokines.
Although the mechanism of action of Mel is limited to the
inhibition of cyclooxygenase-2,80 a key enzyme in the process
of synthesis of prostaglandins (which are mediators of
inﬂammation), Dex interacts with numerous signaling cas-
cades that in turn regulate both inﬂammation and apoptosis.81
These include the p38 mitogen-activated protein kinase and
c-Jun N-terminal kinase pathways.82e85 It is possible that
these signaling pathways play a role in mediating both
inﬂammation and apoptosis as a result of Bb infection in vivo.
A thorough analysis of the differences in the mechanisms of
action of both drugs may provide a blueprint for the devel-
opment of new treatments for LNB.
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